Excellence in Care:
Cardiac Drug Update
Pam Bayles-Prevost RN, BSN
INDEPENDENT STUDY
Health Professions Institute
for Continuing Education
Austin Community College
The Austin Community College
Health Professions Institute, Continuing Education
5930 Middle Fiskville Road, Austin, TX 78752
INDEPENDENT STUDY: HPRX 3003: Excellence in Care: Cardiac Drug Update
Description and Purpose: Pam Bayles-Prevost RN, BSN appears with Elizabeth Huss RN, BSN,
coordinator with the Health Professions Institute of Austin Community College, to discuss current
medications used to treat and manage cardiac events and conditions. Ms. Bayles has 25 years
experience working in critical care in the NICU, PICU, and adult ICU settings. She currently teaches
through the ACC Health Professions Institute and works clinically with the Heart Hospital of Austin.
The purpose of this activity is to enrich the participant’s contribution to quality healthcare and the
pursuit of professional career goals by providing current and updated information on
pharmacological agents used in the prevention, treatment, and management of cardiac conditions.
This offering is a self-paced learning activity developed to meet the individual needs of nurses, social
workers, and emergency medical services personnel requiring continuing education for relicensure.
Goals and Objectives: Upon completion of this activity, the student will be able to:
1. Explain why there is a trend in the number of deaths due to cardiac disease.
2. Identify two (2) classes of drugs used in the treatment of a myocardial infarction (MI).
3. Discuss how Amiodarone is used in the treatment and management of cardiac conditions.
4. Distinguish between medications that inhibit platelet activation and those that inhibit platelet
aggregation.
5. List two (2) parental medications used for the treatment of congestive heart failure (CHF).
6. Describe pharmacogenomics and their anticipated benefits.
Requirements for Successful Completion: The packet you have received contains a pre-test, DVD,
post-test and a program evaluation. To successfully complete this activity and earn continuing
education the participant must:
1. Complete the pre-test
2. View the DVD
3. Complete the post-test (score an 80 or more)
4. And, complete the evaluation
NOTE: Following the viewing of the DVD and completing the accompanying documents, questions
may be addressed by contacting Elizabeth Huss @ 512-223-7271 or [email protected]
Submit all of the documents (pre/post-test, evaluation) along with your completed Registration Form
(check or credit card), and payment to:
Austin Community College
Health Professions Institute
Attn: Online Nursing Videos
5930 Middle Fiskville Rd.
Austin, TX 78752
Fax: 512-223-7030
Within two business weeks from receipt of your material at ACC, your certificate of completion will
be available (to be mailed, fax, or picked up at the above address … your choice).
Upon successful completion participants will be awarded a certificate of successful completion worth
2.0 contact hours.
Austin Community College is an approved provider of continuing nursing education by the Texas
Nurses Association, an accredited approver by the American Nurses Credentialing Center’s
Commission on Accreditation.
Contact hours for programs applicable to social work are approved for CEU’s by the Texas State Board
of Social Worker Examiners. This program is worth 2.0 contact hours or 0.2 continuing education
units (CEU’s).
Continuing education for Emergency Medical Personnel is approved by the Texas Department of
State Health Services. This program is worth 2.0 TDH (P) contact hours.
Disclosure to Attendees: The presenters and planning committee members for this offering have
completed Conflict of Interest forms and it has been determined that no conflict of interest exists or
has been indentified in relation to this offering.
Commercial Support: This offering has not received any commercial support.
Non-endorsement of products: The discussion of generic or brand name items or medications does
not constitute endorsement by the American Nurses Credential Center’s Commission on
Accreditation (ANCC), the Texas Nurses Association (TNA) or Austin Community College.
Off-Label Use: Off-label use of medications refers to the prescribing of medications to treat a
condition for which the medication has not been approved by the Food and Drug Administration.
Medications presented in this activity will only be discussed in the context of their Federal Drug
Administration (FDA) approval.
Expiration: This continuing nursing education activity (Cardiac Drug Update) will expire on October 1,
2014.
Printed Name:
Date:
Instructions: Complete this pre-test PRIOR to watching the video. Choose the best answer by circling
the letter corresponding to your choice. Submit your post-test, completed evaluation, completed
registration, and payment to:
Austin Community College
Health Professions Institute
Attn: Online Nursing Videos
5930 Middle Fiskville Rd.
Austin, TX 78752
Fax: 512-223-7030
Pre-Test: Cardiac Drug Update
1. There has been a decreasing trend in the number of deaths associated with cardiac disease in the
U.S. This is in part due to:
a. The increase in number of physicians specializing in cardiac care.
b. The development of new medications for lowering cholesterol (Statins).
c. Public awareness of pharmaceutical agents used to increase cholesterol.
d. More people participating in fad diets.
2. The development of Statins has allowed individuals and healthcare providers to have better
control over blood lipid levels. Normal levels are:
a. Total Cholesterol < 200; Triglycerides <150; HDL >50; LDL <50
b. Total Cholesterol <200; Triglycerides >150; HDL <50; LDL <50
c. Total Cholesterol <200; Triglycerides <150; HDL >50; LDL >50
d. Total Cholesterol >200; Triglycerides <150; HDL >50; LDL <50
3. C-Reactive proteins are:
a. Proteins found in meat that causes a cardiac reaction in the body.
b. Proteins found in the body that react to cholesterol lowering agents.
c. Proteins found in the blood, typically associated with inflammatory & infectious processes.
d. A lab level that is a predicator of overall good cardiac health.
4. In addition to lowering cholesterol Statins:
a. Stabilize arterial plaque and increase inflammation.
b. Stabilize arterial plaque and increase C-Reactive proteins.
c. Typically work within 1 week and destabilize plaque.
d. Decrease the size of plaque and decrease inflammation.
Pre-Test Pg. 2
Cardiac Drugs
5. Angiotension II causes:
a. Vasodilatation leading to elevated blood pressure.
b. Vasoconstriction leading to elevated blood pressure.
c. A only
d. Neither A nor B
6. ACE-Inhibitors work because they block the conversion of Angiotension I to Angiotension II and are
indicated for:
a. Diabetes, Hypertension, and Coronary Heart Failure (CHF)
b. Elevated Triglycerides, Myocardial Infarction (MI), and Coronary Heart Failure (CHF)
c. High Blood Pressure, Myocardial Infarction (MI), and Congestive Heart Failure (CHF)
d. Multiple Infections (MI), Hypertension, and Congestive Heart Failure (CHF)
7. Side effects of Amiodarone include:
a. Pulmonary toxicity with prolonged administration
b. Red-flushing color of skin.
c. Elevation in total cholesterol.
d. Interaction with simvastatin which can lead to liver failure.
8. Glycoprotein IIb/IIIb inhibitors:
a. Are given when the ambulance arrives on the scene of a reported chest pain.
b. Are administered PO, IM, and IV.
c. Stop platelets from working (inhibit platelet activation).
d. Are administrated when clients are going to the cath lab.
9. These two (2) drugs are used in the treatment of congestive heart failure and are given parentally:
a. Nesiritide and Angiomax
b. Natrecor and Primacor
c. Primacor and Vasopressin
d. Natrecor and Plavix
10. This drug is a synthetic version of a naturally occurring substance found in the saliva of leeches:
a. Abciximab
b. Clopidogrel
c. Angiomax
d. Tirofibin
Pre-Test Pg. 3
Cardiac Drugs
11. Angiomax is indicated for individuals who are at risk for HIT/HITTS. HIT/HITTS is an immune
mediated disorder that occurs 4-10 days after exposure to heparin. It can cause:
a. An increase in platelets leading to a break-up of clots.
b. Pancytopenia.
c. An increase in red blood cells leading to the development of blood clots.
d. Thrombocytopenia.
12. The following drugs inhibit platelet activation:
a. Aspirin, Angiomax, Heparin, Plavix
b. Angiomax, Aspirin, Aggrastat, Reopro
c. IIb/IIIb inhibitors, ASA, Heparin, Plavix
d. Abciximab, Aspirin, Angiomax, Aggrastat
13. The following drugs inhibit platelet aggregation:
a. Abciximab, Eptifibitide, ASA, Plavix
b. Abciximab, Aspirin, Angiomax, Aggrastat
c. Abciximab, Aggrastat, Intregrillin, IIb/IIIb Inhibitors
d. Aggrastat, ASA, Intregrillin, Reopro
14. This drug raises blood pressure with no effect on the heart, is the drug of choice (over
epinephrine), and used to treat asystole and shock:
a. Primacor
b. Vasopressin
c. Natrecor
d. Angiomax
15. This drug works to increase cardiac output without increasing the heart rate or demand on the
heart:
a. Vasopressin
b. Natrecor
c. Angiomax
d. Primacor
Excellence in Care: Cardiac Drug Update
Program Outline
Written:
I. Pre-Test
DVD Presentation:
II. Overview: Advances in Cardiovascular Medicine
A. Current statistics- deaths due to Coronary Artery Disease (CAD)
B. Advances in cardiac pharmacology
III. New Cardiac Medications: The following classifications and drugs are individually discussed on the video.
Each Drug is presented and includes classification, mechanism of action, indication, dosing/administration, and
special considerations.
A. Statins
B. ACE-Inhibitors
C. Amiodarone
D. Clopidogrel (Plavix)
E. Glycoprotein IIb/IIIa Inhibitors
F. Angiomax (Bivalirudin)
G. Platelet Inhibitors
H. Vasopressin
I. Natrecor (Nesiritide)
J. Primacor
IV. The Future of Cardiac Pharmacology, Management
A. Pharmacogenomics
B. Cardiac Myosin Activators
C. Alpha Natriuretic Peptide medications
D. Stem Cell Research
E. Computers and Imaging Techniques
V. Summary
Written:
VI. Post-Test
VII. Evaluation
Evaluation
Title of Education Activity: Excellence in Care: Cardiac Drug Update
Location: DVD Video Format
Date: Participants check out and complete on own time
Purpose of this activity: The purpose of this activity is to enrich the participant’s contribution to
quality healthcare and the pursuit of professional career goals by providing current and updated
information on pharmacological agents used in the prevention, treatment, and management of
cardiac conditions.
Directions/Instructions: Please complete this evaluation questionnaire. Your anonymous
responses will be used to revise this activity and to plan future educational activities. Circle the
number that best fits your evaluation of this activity.
1 = Not at all
2 = Somewhat
3 = Almost completely
4 = Completely
1. Rate your achievement of these objectives:
1. Explain why there is a trend in the number of
deaths due to cardiac disease.
1
2
3
4
2. Identify two (2) classes of drugs used in the
treatment of a myocardial infarction (MI).
1
2
3
4
3. Discuss how Amiodarone is used in the treatment
and management of cardiac conditions.
1
2
3
4
4. Distinguish between medications that inhibit platelet
activation and those that inhibit platelet aggregation.
1
2
3
4
5. List two (2) parental medications used for the treatment
of congestive heart failure (CHF).
1
2
3
4
6. Describe pharmacogenomics and their anticipated benefits.
1
2
3
4
2. Rate the effectiveness of the teaching/learning resources?
1
2
3
4
1
1
1
2
2
2
3
3
3
4
4
4
3. Please evaluate the guest speaker- Pamela Bayles RN, BSN
a. Knowledge and currency of topic
b. Ability to make points clear
c. Ability to apply content to practice
4. Please evaluate the moderator- Elizabeth Huss RN, BSN
a. Guides the discussion
b. Asks pertinent questions
c. Fosters clarification of presented information
5. Were the objectives relevant to the overall purpose?
(see above)
1
1
1
2
2
2
3
3
3
4
4
4
1
2
3
4
5. How long (in minutes) did it take you to complete the entire activity (including taking the pretest, watching the video, taking the post-test, and completing this evaluation tool)? ________
Minutes
6. List two (2) ways you will integrate what you learned in this activity into your practice and/or
employment environment.
8. The following were disclosed prior to the beginning of this activity either in writing or verbally?
a. Requirements for successful completion
b. Conflicts of Interest
c. Commercial Support
d. Non-endorsement of Products
e. Off-label Use
9. Did you, as a participant, notice any bias that was not previously
presentation?
Yes
Yes
Yes
Yes
Yes
disclosed in this
Yes
No
If “Yes”, please describe who was biased and how.
10. Comments: If you answered (1) to any of the above, please comment.
11. Please list any suggestions or topics for future programming.
No
No
No
No
No
Printed Name:
Date:
Address (where you would like to receive your certificate of completion):
City:
State:
Zip code:
Instructions: Choose the best answer for each question listed below and circle the corresponding letter. A
passing score of 80% (answer 12 or more correctly) or more is required to earn continuing nursing education
(CNE). After you have completed this post-test, submit it along with your completed evaluation, pre-test,
registration form and payment to the address below:
Austin Community College
Health Professions Institute
Attn: Online Nursing Videos
5930 Middle Fiskville Rd.
Austin, TX 78752
Fax: 512-223-7030
Post-Test: Cardiac Drug Update
1. There has been a decreasing trend in the number of deaths associated with cardiac disease in the
U.S. This is in part due to:
a. The increase in number of physicians specializing in cardiac care.
b. The development of new medications for lowering cholesterol (Statins).
c. Public awareness of pharmaceutical agents used to increase cholesterol.
d. More people participating in fad diets.
2. The development of Statins has allowed individuals and healthcare providers to have better
control over blood lipid levels. Normal levels are:
a. Total Cholesterol < 200; Triglycerides <150; HDL >50; LDL <50
b. Total Cholesterol <200; Triglycerides >150; HDL <50; LDL <50
c. Total Cholesterol <200; Triglycerides <150; HDL >50; LDL >50
d. Total Cholesterol >200; Triglycerides <150; HDL >50; LDL <50
3. C-Reactive proteins are:
a. Proteins found in meat that causes a cardiac reaction in the body.
b. Proteins found in the body that react to cholesterol lowering agents.
c. Proteins found in the blood, typically associated with inflammatory & infectious processes.
d. A lab level that is a predicator of overall good cardiac health.
Post-Test Pg. 2
Cardiac Drugs
4. In addition to lowering cholesterol Statins:
a. Stabilize arterial plaque and increase inflammation.
b. Stabilize arterial plaque and increase C-Reactive proteins.
c. Typically work within 1 week and destabilize plaque.
d. Decrease the size of plaque and decrease inflammation.
5. Angiotension II causes:
a. Vasodilatation leading to elevated blood pressure.
b. Vasoconstriction leading to elevated blood pressure.
c. A only
d. Neither A nor B
6. ACE-Inhibitors work because they block the conversion of Angiotension I to Angiotension II and are
indicated for:
a. Diabetes, Hypertension, and Coronary Heart Failure (CHF)
b. Elevated Triglycerides, Myocardial Infarction (MI), and Coronary Heart Failure (CHF)
c. High Blood Pressure, Myocardial Infarction (MI), and Congestive Heart Failure (CHF)
d. Multiple Infections (MI), Hypertension, and Congestive Heart Failure (CHF)
7. Side effects of Amiodarone include:
a. Pulmonary toxicity with prolonged administration
b. Red-flushing color of skin.
c. Elevation in total cholesterol.
d. Interaction with simvastatin which can lead to liver failure.
8. Glycoprotein IIb/IIIb inhibitors:
a. Are given when the ambulance arrives on the scene of a reported chest pain.
b. Are administered PO, IM, and IV.
c. Stop platelets from working (inhibit platelet activation).
d. Are administrated when clients are going to the cath lab.
9. These two (2) drugs are used in the treatment of congestive heart failure and are given parentally:
a. Nesiritide and Angiomax
b. Natrecor and Primacor
c. Primacor and Vasopressin
d. Natrecor and Plavix
Post-Test Pg. 3
Cardiac Drugs
10. This drug is a synthetic version of a naturally occurring substance found in the saliva of leeches:
a. Abciximab
b. Clopidogrel
c. Angiomax
d. Tirofibin
11. Angiomax is indicated for individuals who are at risk for HIT/HITTS. HIT/HITTS is an immune
mediated disorder that occurs 4-10 days after exposure to heparin. It can cause:
a. An increase in platelets leading to a break-up of clots.
b. Pancytopenia.
c. An increase in red blood cells leading to the development of blood clots.
d. Thrombocytopenia.
12. The following drugs inhibit platelet activation:
a. Aspirin, Angiomax, Heparin, Plavix
b. Angiomax, Aspirin, Aggrastat, Reopro
c. IIb/IIIb inhibitors, ASA, Heparin, Plavix
d. Abciximab, Aspirin, Angiomax, Aggrastat
13. The following drugs inhibit platelet aggregation:
a. Abciximab, Eptifibitide, ASA, Plavix
b. Abciximab, Aspirin, Angiomax, Aggrastat
c. Abciximab, Aggrastat, Intregrillin, IIb/IIIb Inhibitors
d. Aggrastat, ASA, Intregrillin, Reopro
14. This drug raises blood pressure with no effect on the heart, is the drug of choice (over
epinephrine), and used to treat asystole and shock:
a. Primacor
b. Vasopressin
c. Natrecor
d. Angiomax
15. This drug works to increase cardiac output without increasing the heart rate or demand on the
heart:
a. Vasopressin
b. Natrecor
c. Angiomax
d. Primacor